These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 29232070)

  • 1. Schedules of Controlled Substances: Placement of FDA-Approved Products of Oral Solutions Containing Dronabinol [(-)-delta-9-trans- tetrahydrocannabinol (delta-9-THC)] in Schedule II. Final rule.
    Drug Enforcement Administration, Department of Justice.
    Fed Regist; 2017 Nov; 82(224):55504-6. PubMed ID: 29232070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Schedules of Controlled Substances: Placement of FDA-Approved Products of Oral Solutions Containing Dronabinol [(-)-delta-9-transtetrahydrocannabinol (delta-9-THC)] in Schedule II. Interim final rule, with request for comments.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2017 Mar; 82(55):14815-20. PubMed ID: 28355049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Schedules of controlled substances: rescheduling of the Food and Drug Administration approved product containing synthetic dronabinol [(-) - [DELTA] less than 9 greater than - (trans)-tetrahydrocannabinol] in sesame oil and encapsulated in soft gelatin capsules from schedule II to schedule III. Department of Justice (DOJ), Drug Enforcement Administration (DEA). Final rule.
    Fed Regist; 1999 Jul; 64(127):35928-30. PubMed ID: 10558581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Schedules of Controlled Substances: Placement of Brivaracetam Into Schedule V. Final rule.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2017 Mar; 82(45):13067-9. PubMed ID: 28355045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Schedules of controlled substances: rescheduling of buprenorphine from schedule V to schedule III. Final rule.
    Drug Enforcement Administration (DEA), Department of Justice
    Fed Regist; 2002 Oct; 67(194):62354-70. PubMed ID: 12369590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Schedules of Controlled Substances: Table of Excluded Nonnarcotic Products: Nasal Decongestant Inhaler/Vapor Inhaler. Final rule.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2016 Feb; 81(25):6453-4. PubMed ID: 26859907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Schedules of Controlled Substances: Placement of Thiafentanil Into Schedule II. Interim final rule with request for comments.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2016 Aug; 81(166):58834-40. PubMed ID: 27568479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of a chemical precursor used in the illicit manufacture of fentanyl as a List I chemical. Final rule.
    Drug Enforcement Administration (DEA), Department of Justice
    Fed Regist; 2008 Jul; 73(144):43355-7. PubMed ID: 18949877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Schedules of controlled substances: placement of lisdexamfetamine into schedule II. Final rule.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2007 May; 72(85):24532-4. PubMed ID: 17520775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Schedules of Controlled Substances: Placement in Schedule V of Certain FDA-Approved Drugs Containing Cannabidiol; Corresponding Change to Permit Requirements. Final order.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2018 Sep; 83(189):48950-3. PubMed ID: 30272400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Schedules of Controlled Substances: Placement of Brivaracetam Into Schedule V. Interim final rule, with request for comments.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2016 May; 81(92):29487-92. PubMed ID: 27192732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Schedules of controlled substances: placement of Zopiclone into schedule IV. Final rule.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2005 Apr; 70(63):16935-7. PubMed ID: 15806735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elimination of exemptions for chemical mixtures containing the list I chemicals ephedrine and/or pseudoephedrine. Final rule.
    Drug Enforcement Administration (DEA), Department of Justice
    Fed Regist; 2008 Jul; 73(133):39611-4. PubMed ID: 18850676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Schedules of controlled substances: placement of tapentadol into schedule II. Final rule.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2009 May; 74(97):23790-3. PubMed ID: 19507329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Schedules of controlled substances: placement of pregabalin into schedule V. Final rule.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2005 Jul; 70(144):43633-5. PubMed ID: 16050051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Schedules of controlled substances: placement of alpha-methyltryptamine and 5-methoxy-N,N-diisopropyltryptamine into schedule I of the Controlled Substances Act. Final rule.
    Drug Enforcement Administration (DEA), Department of Justice
    Fed Regist; 2004 Sep; 69(188):58950-3. PubMed ID: 15455477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Schedules of Controlled Substances: Table of Excluded Nonnarcotic Products: Vicks® VapoInhaler®.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2016 Feb; 81(25):6451-3. PubMed ID: 26859905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Schedules of controlled substances: placement of 5-methoxy-N,N-dimethyltryptamine into Schedule I of the Controlled Substances Act. Final rule.
    Drug Enforcement Administration (DEA), Department of Justice
    Fed Regist; 2010 Dec; 75(243):79296-300. PubMed ID: 21171485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Schedules of controlled substances; placement of 2,5-dimethoxy-4-(n)-propylthiophenethylamine and N-benzylpiperazine into Schedule I of the Controlled Substances Act. Final rule.
    Drug Enforcement Administration (DEA), Department of Justice
    Fed Regist; 2004 Mar; 69(53):12794-7. PubMed ID: 15029891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Schedule of controlled substances; placement of fospropofol into schedule IV. Final rule.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2009 Oct; 74(192):51234-6. PubMed ID: 19877370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.